Qin Li, Favis Nicole, Famulski Jakub, Evans David H
Department of Medical Microbiology & Immunology and Li Ka Shing Institute of Virology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB, Canada.
Department of Medical Microbiology & Immunology and Li Ka Shing Institute of Virology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB, Canada
J Virol. 2015 Feb;89(3):1809-24. doi: 10.1128/JVI.02797-14. Epub 2014 Nov 19.
Although vaccinia virus (VACV) was once used as a vaccine to eradicate smallpox on a worldwide scale, the biological origins of VACV are uncertain, as are the historical relationships between the different strains once used as smallpox vaccines. Here, we sequenced additional VACV strains that either represent relatively pristine examples of old vaccines (e.g., Dryvax, Lister, and Tashkent) or have been subjected to additional laboratory passage (e.g., IHD-W and WR). These genome sequences were compared with those previously reported for other VACVs as well as other orthopoxviruses. These extant VACVs do not always cluster in simple phylogenetic trees that are aligned with the known historical relationships between these strains. Rather, the pattern of deletions suggests that all existing strains likely come from a complex stock of viruses that has been passaged, distributed, and randomly sampled over time, thus obscuring simple historical or geographic links. We examined surviving nonclonal vaccine stocks, like Dryvax, which continue to harbor larger and now rare variants, including one that we have designated "clone DPP25." DPP25 encodes genes not found in most VACV strains, including an ankyrin-F-box protein, a homolog of the variola virus (Bangladesh) B18R gene which we show can be deleted without affecting virulence in mice. We propose a simple common mechanism by which recombination of a larger and hypothetical DPP25-like ancestral strain, combined with selection for retention of critically important genes near the terminal inverted repeat boundaries (vaccinia virus growth factor gene and an interferon alpha/beta receptor homolog), could produce all known VACV variants.
Smallpox was eradicated by using a combination of intensive disease surveillance and vaccination using vaccinia virus (VACV). Interestingly, little is known about the historical relationships between different strains of VACV and how these viruses may have evolved from a common ancestral strain. To understand these relationships, additional strains were sequenced and compared to existing strains of VACV as well as other orthopoxviruses by using whole-genome sequence alignments. Extant strains of VACV did not always cluster in simple phylogenetic trees based on known historical relationships between these strains. Based on these findings, it is possible that all existing strains of VACV are derived from a single complex stock of viruses that has been passaged, distributed, and sampled over time.
尽管痘苗病毒(VACV)曾被用作疫苗在全球范围内根除天花,但VACV的生物学起源尚不确定,曾用作天花疫苗的不同毒株之间的历史关系也不明确。在此,我们对另外一些VACV毒株进行了测序,这些毒株要么代表旧疫苗相对原始的样本(如Dryvax、Lister和塔什干株),要么经过了额外的实验室传代(如IHD-W和WR)。将这些基因组序列与先前报道的其他VACV以及其他正痘病毒的序列进行了比较。这些现存的VACV在简单的系统发育树中并不总是按照与这些毒株已知的历史关系聚类。相反,缺失模式表明所有现有毒株可能都来自一个复杂的病毒库,该病毒库随着时间的推移经过传代、传播和随机抽样,从而模糊了简单的历史或地理联系。我们研究了存活的非克隆疫苗株,如Dryvax,它仍然含有更大且现在罕见的变体,包括我们命名为“克隆DPP25”的一个变体。DPP25编码在大多数VACV毒株中未发现的基因,包括一个锚蛋白-F盒蛋白,这是天花病毒(孟加拉国株)B18R基因的同源物,我们发现该基因缺失后不影响小鼠的毒力。我们提出了一种简单的共同机制,即一个更大的、假设的类似DPP25的祖先毒株发生重组,再加上对末端反向重复边界附近至关重要的基因(痘苗病毒生长因子基因和干扰素α/β受体同源物)保留的选择,可能产生了所有已知的VACV变体。
天花是通过强化疾病监测和使用痘苗病毒(VACV)进行疫苗接种相结合的方式被根除的。有趣的是,人们对不同VACV毒株之间的历史关系以及这些病毒可能如何从一个共同的祖先毒株进化而来知之甚少。为了理解这些关系,我们对另外一些毒株进行了测序,并通过全基因组序列比对将其与现有的VACV毒株以及其他正痘病毒进行了比较。基于这些毒株已知的历史关系,现存的VACV毒株在简单的系统发育树中并不总是聚类在一起。基于这些发现,所有现有的VACV毒株有可能都源自一个单一的复杂病毒库,该病毒库随着时间的推移经过了传代、传播和抽样。